Found: 40
Select item for more details and to access through your institution.
Comment on López-Yerena et al. "Absorption and Intestinal Metabolic Profile of Oleocanthal in Rats" Pharmaceutics 2020, 12, 134.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Optimization of Taste-Masked (–)-Oleocanthal Effervescent Formulation with Potent Breast Cancer Progression and Recurrence Suppressive Activities.
- Published in:
- Pharmaceutics, 2019, v. 11, n. 10, p. 515, doi. 10.3390/pharmaceutics11100515
- By:
- Publication type:
- Article
Discovery, Optimization, and Pharmacophore Modeling of Oleanolic Acid and Analogues as Breast Cancer Cell Migration and Invasion Inhibitors Through Targeting Brk/Paxillin/Rac1 Axis.
- Published in:
- Chemical Biology & Drug Design, 2015, v. 85, n. 2, p. 231, doi. 10.1111/cbdd.12380
- By:
- Publication type:
- Article
Graviola (Annona muricata) Exerts Anti-Proliferative, Anti-Clonogenic and Pro-Apoptotic Effects in Human Non-Melanoma Skin Cancer UW-BCC1 and A431 Cells In Vitro: Involvement of Hedgehog Signaling.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 6, p. 1791, doi. 10.3390/ijms19061791
- By:
- Publication type:
- Article
Optimization of (Phenylmethylidene)-hydantoins as Prostate Cancer Migration Inhibitors: SAR-Directed Design, Synthesis, and Pharmacophore Modeling.
- Published in:
- Chemistry & Biodiversity, 2011, v. 8, n. 8, p. 1470, doi. 10.1002/cbdv.201000248
- By:
- Publication type:
- Article
Discovery and preliminary structure-activity relationship of the marine natural product manzamines as herpes simplex virus type-1 inhibitors.
- Published in:
- Zeitschrift für Naturforschung. Section C: A Journal of Biosciences, 2017, v. 72, n. 1/2, p. 49, doi. 10.1515/znc-2016-0080
- By:
- Publication type:
- Article
Anticancer Properties of Graviola (Annona muricata): A Comprehensive Mechanistic Review.
- Published in:
- Oxidative Medicine & Cellular Longevity, 2018, p. 1, doi. 10.1155/2018/1826170
- By:
- Publication type:
- Article
Oleocanthal Attenuates Metastatic Castration-Resistant Prostate Cancer Progression and Recurrence by Targeting SMYD2.
- Published in:
- Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143542
- By:
- Publication type:
- Article
(−)-Oleocanthal Prevents Breast Cancer Locoregional Recurrence After Primary Tumor Surgical Excision and Neoadjuvant Targeted Therapy in Orthotopic Nude Mouse Models.
- Published in:
- Cancers, 2019, v. 11, n. 5, p. 637, doi. 10.3390/cancers11050637
- By:
- Publication type:
- Article
Pseurotin A Validation as a Metastatic Castration-Resistant Prostate Cancer Recurrence-Suppressing Lead via PCSK9-LDLR Axis Modulation.
- Published in:
- Marine Drugs, 2023, v. 21, n. 4, p. 215, doi. 10.3390/md21040215
- By:
- Publication type:
- Article
The Maxi-K (BK) Channel Antagonist Penitrem A as a Novel Breast Cancer-Targeted Therapeutic.
- Published in:
- Marine Drugs, 2018, v. 16, n. 5, p. 157, doi. 10.3390/md16050157
- By:
- Publication type:
- Article
Astaxanthin and Docosahexaenoic Acid Reverse the Toxicity of the Maxi-K (BK) Channel Antagonist Mycotoxin Penitrem A.
- Published in:
- Marine Drugs, 2016, v. 14, n. 11, p. 208, doi. 10.3390/md14110208
- By:
- Publication type:
- Article
Discovery of Novel Antiangiogenic Marine Natural Product Scaffolds.
- Published in:
- Marine Drugs, 2016, v. 14, n. 3, p. 57, doi. 10.3390/md14030057
- By:
- Publication type:
- Article
Esters of the Marine-Derived Triterpene Sipholenol A Reverse P-GP-Mediated Drug Resistance.
- Published in:
- Marine Drugs, 2015, v. 13, n. 4, p. 2267, doi. 10.3390/md13042267
- By:
- Publication type:
- Article
Araguspongine C Induces Autophagic Death in Breast Cancer Cells through Suppression of c-Met and HER2 Receptor Tyrosine Kinase Signaling.
- Published in:
- Marine Drugs, 2015, v. 13, n. 1, p. 288, doi. 10.3390/md13010288
- By:
- Publication type:
- Article
The Marine-Derived Sipholenol A-4-O-3',4'-Dichlorobenzoate Inhibits Breast Cancer Growth and Motility in Vitro and in Vivo through the Suppression of Brk and FAK Signaling.
- Published in:
- Marine Drugs, 2014, v. 12, n. 6, p. 2282, doi. 10.3390/md12042282
- By:
- Publication type:
- Article
The Marine-Derived Sipholenol A-4-O-3',4'-Dichlorobenzoate Inhibits Breast Cancer Growth and Motility in Vitro and in Vivo through the Suppression of Brk and FAK Signaling.
- Published in:
- Marine Drugs, 2014, v. 12, n. 4, p. 2282, doi. 10.3390/md12042282
- By:
- Publication type:
- Article
Subereamolline A as a Potent Breast Cancer Migration, Invasion and Proliferation Inhibitor and Bioactive Dibrominated Alkaloids from the Red Sea Sponge Pseudoceratina arabica.
- Published in:
- Marine Drugs, 2012, v. 10, n. 11, p. 2492, doi. 10.3390/md10112492
- By:
- Publication type:
- Article
Current Status on Marine Products with Reversal Effect on Cancer Multidrug Resistance.
- Published in:
- Marine Drugs, 2012, v. 10, n. 10, p. 2312, doi. 10.3390/md10102312
- By:
- Publication type:
- Article
Towards Developing Novel Prostate Cancer Recurrence Suppressors: Acute Toxicity of Pseurotin A, an Orally Active PCSK9 Axis-Targeting Small-Molecule in Swiss Albino Mice.
- Published in:
- Molecules, 2023, v. 28, n. 3, p. 1460, doi. 10.3390/molecules28031460
- By:
- Publication type:
- Article
Selective growth inhibition of human malignant melanoma cells by syringic acid-derived proteasome inhibitors.
- Published in:
- Cancer Cell International, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1475-2867-13-82
- By:
- Publication type:
- Article
Sipholenol A, a marine-derived sipholane triterpene, potently reverses P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.
- Published in:
- Cancer Science, 2007, v. 98, n. 9, p. 1373, doi. 10.1111/j.1349-7006.2007.00554.x
- By:
- Publication type:
- Article
Acylated Iridoids and Rhamnopyranoses from Premna odorata (Lamiaceae) as Novel Mesenchymal-Epithelial Transition Factor Receptor Inhibitors for the Control of Breast Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Norstictic Acid Inhibits Breast Cancer Cell Proliferation, Migration, Invasion, and In Vivo Invasive Growth Through Targeting C-Met.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Olive Oil-derived Oleocanthal as Potent Inhibitor of Mammalian Target of Rapamycin: Biological Evaluation and Molecular Modeling Studies.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Antiproliferative potential of sarcophine and its semisynthetic sulfur-containing derivatives against human mammary carcinoma cell lines.
- Published in:
- Journal of Natural Medicines, 2007, v. 61, n. 2, p. 154, doi. 10.1007/s11418-006-0113-8
- By:
- Publication type:
- Article
13<sup>1</sup>‐Oxophorbine protopheophorbide A from Ziziphus lotus as a novel mesenchymal‐epithelial transition factor receptor inhibitory lead for the control of breast tumor growth in vitro and in vivo.
- Published in:
- Molecular Carcinogenesis, 2018, v. 57, n. 11, p. 1507, doi. 10.1002/mc.22874
- By:
- Publication type:
- Article
Novel liquid-liquid extraction and self-emulsion methods for simplified isolation of extra-virgin olive oil phenolics with emphasis on (-)-oleocanthal and its oral anti-breast cancer activity.
- Published in:
- PLoS ONE, 2019, v. 14, n. 4, p. 1, doi. 10.1371/journal.pone.0214798
- By:
- Publication type:
- Article
Optimization of Marine Triterpene Sipholenols as Inhibitors of Breast Cancer Migration and Invasion.
- Published in:
- ChemMedChem, 2013, v. 8, n. 3, p. 497, doi. 10.1002/cmdc.201200516
- By:
- Publication type:
- Article
S -(−)-Oleocanthal Ex Vivo Modulatory Effects on Gut Microbiota.
- Published in:
- Nutrients, 2023, v. 15, n. 3, p. 618, doi. 10.3390/nu15030618
- By:
- Publication type:
- Article
The Tobacco β-Cembrenediol: A Prostate Cancer Recurrence Suppressor Lead and Prospective Scaffold via Modulation of Indoleamine 2,3-Dioxygenase and Tryptophan Dioxygenase.
- Published in:
- Nutrients, 2022, v. 14, n. 7, p. 1505, doi. 10.3390/nu14071505
- By:
- Publication type:
- Article
Polyphenols Modulating Effects of PD-L1/PD-1 Checkpoint and EMT-Mediated PD-L1 Overexpression in Breast Cancer.
- Published in:
- Nutrients, 2021, v. 13, n. 5, p. 1718, doi. 10.3390/nu13051718
- By:
- Publication type:
- Article
Comparative Gene Signature of (−)-Oleocanthal Formulation Treatments in Heterogeneous Triple Negative Breast Tumor Models: Oncological Therapeutic Target Insights.
- Published in:
- Nutrients, 2021, v. 13, n. 5, p. 1706, doi. 10.3390/nu13051706
- By:
- Publication type:
- Article
(-)-Oleocanthal Nutraceuticals for Alzheimer's Disease Amyloid Pathology: Novel Oral Formulations, Therapeutic, and Molecular Insights in 5xFAD Transgenic Mice Model.
- Published in:
- Nutrients, 2021, v. 13, n. 5, p. 1702, doi. 10.3390/nu13051702
- By:
- Publication type:
- Article
Advances in NAD-Lowering Agents for Cancer Treatment.
- Published in:
- Nutrients, 2021, v. 13, n. 5, p. 1665, doi. 10.3390/nu13051665
- By:
- Publication type:
- Article
Breast Cancer Survivors Undergoing Endocrine Therapy Have a Worrying Risk Factor Profile for Cardiovascular Diseases.
- Published in:
- Nutrients, 2021, v. 13, n. 4, p. 1114, doi. 10.3390/nu13041114
- By:
- Publication type:
- Article
(−)-Oleocanthal as a Dual c-MET-COX2 Inhibitor for the Control of Lung Cancer.
- Published in:
- Nutrients, 2020, v. 12, n. 6, p. 1749, doi. 10.3390/nu12061749
- By:
- Publication type:
- Article
Safety Evaluations of Single Dose of the Olive Secoiridoid S-(−)-Oleocanthal in Swiss Albino Mice.
- Published in:
- Nutrients, 2020, v. 12, n. 2, p. 314, doi. 10.3390/nu12020314
- By:
- Publication type:
- Article
(−)-Oleocanthal Combined with Lapatinib Treatment Synergized against HER-2 Positive Breast Cancer In Vitro and In Vivo.
- Published in:
- Nutrients, 2019, v. 11, n. 2, p. 412, doi. 10.3390/nu11020412
- By:
- Publication type:
- Article
Paraoxonase-1, malondialdehyde and glutathione reductase in Type 2 Diabetic patients with nephropathy.
- Published in:
- Eastern Journal of Medicine, 2014, v. 19, n. 4, p. 169
- By:
- Publication type:
- Article